Dr Reddy's Laboratories Q3 Results

  • BSE: 500124
  • NSE: DRREDDY
  • ISIN: INE089A01031
  • Sector: Biotechnology & Drugs
BSE
1,369.75-10.25 (-0.74%)
Volume5.85 K
Updated: Tue 17 Nov, 2026 | 09:49:51
NSE
1,370.30-7.60 (-0.55%)
Volume81.01 K
Updated: Tue 17 Nov, 2026 | 09:35:09
Today: 1,368.35
1,376.70
52-Wk: 1,080.05
1,414.40

Q3 Results Highlights

Quarter ended Dec 25

    Note: Comparison is on QoQ basis

    Quarterly - Dr Reddy's Laboratories Q3 Results

    *All figures in crores except per share values
    Fiscal PeriodDec 25Sep 24QoQ CompDec 24YoY Comp
    Total Operating Expense 7,386.906,358.700.87%6,579.6012.27%
    Depreciation/ Amortization 521.00397.003.25%471.4010.52%
    Operating Income 1,366.501,679.50-9.22%1,801.60-24.15%
    Net Income 1,209.901,255.70-10.18%1,413.70-14.42%
    Other Operating Expenses Total 2,155.10--0.93%-N/A
    Net Income Before Taxes 1,543.201,917.40-11.55%1,874.30-17.67%
    Total Revenue 8,753.408,038.20-0.85%8,381.204.44%
    Selling/ General/ Admin Expenses Total 1,588.503,502.609.39%3,527.10-54.96%
    Diluted Normalized EPS 14.7715.85-12.03%16.94-12.79%
    Recommended For You

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe

        Trending Now In Market